• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于从晚期慢性肾病患者中识别正在接受透析治疗患者的算法的开发与验证

Development and validation of an algorithm for identifying patients undergoing dialysis from patients with advanced chronic kidney disease.

作者信息

Imaizumi Takahiro, Yokota Takashi, Funakoshi Kouta, Yasuda Kazushi, Hattori Akiko, Morohashi Akemi, Kusakabe Tatsumi, Shojima Masumi, Nagamine Sayoko, Nakano Toshiaki, Huang Yong, Morinaga Hiroshi, Ohta Miki, Nagashima Satomi, Inoue Ryusuke, Nakamura Naoki, Ota Hideki, Maruyama Tatsuya, Gobara Hideo, Endoh Akira, Ando Masahiko, Shiratori Yoshimune, Maruyama Shoichi

机构信息

Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 464-8550, Japan.

Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.

出版信息

Clin Exp Nephrol. 2025 May;29(5):650-661. doi: 10.1007/s10157-024-02614-3. Epub 2025 Jan 6.

DOI:10.1007/s10157-024-02614-3
PMID:39762534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12049401/
Abstract

BACKGROUND

Identifying patients on dialysis among those with an estimated glomerular filtration rate (eGFR) < 15 mL/min/1.73 m remains challenging. To facilitate clinical research in advanced chronic kidney disease (CKD) using electronic health records, we aimed to develop algorithms to identify dialysis patients using laboratory data obtained in routine practice.

METHODS

We collected clinical data of patients with an eGFR < 15 mL/min/1.73 m from six clinical research core hospitals across Japan: four hospitals for the derivation cohort and two for the validation cohort. The candidate factors for the classification models were identified using logistic regression with stepwise backward selection. To ensure transplant patients were not included in the non-dialysis population, we excluded individuals with the disease code Z94.0.

RESULTS

We collected data from 1142 patients, with 640 (56%) currently undergoing hemodialysis or peritoneal dialysis (PD), including 426 of 763 patients in the derivation cohort and 214 of 379 patients in the validation cohort. The prescription of PD solutions perfectly identified patients undergoing dialysis. After excluding patients prescribed PD solutions, seven laboratory parameters were included in the algorithm. The areas under the receiver operation characteristic curve were 0.95 and 0.98 and the positive and negative predictive values were 90.9% and 91.4% in the derivation cohort and 96.2% and 94.6% in the validation cohort, respectively. The calibrations were almost linear.

CONCLUSIONS

We identified patients on dialysis among those with an eGFR < 15 ml/min/1.73 m. This study paves the way for database research in nephrology, especially for patients with non-dialysis-dependent advanced CKD.

摘要

背景

在估算肾小球滤过率(eGFR)<15ml/min/1.73m²的患者中识别透析患者仍然具有挑战性。为了利用电子健康记录促进晚期慢性肾脏病(CKD)的临床研究,我们旨在开发算法,通过常规实践中获得的实验室数据识别透析患者。

方法

我们收集了来自日本六家临床研究核心医院的eGFR<15ml/min/1.73m²患者的临床数据:四家医院用于推导队列,两家用于验证队列。使用逐步向后选择的逻辑回归确定分类模型的候选因素。为确保移植患者不被纳入非透析人群,我们排除了疾病编码为Z94.0的个体。

结果

我们收集了1142例患者的数据,其中640例(56%)目前正在接受血液透析或腹膜透析(PD),包括推导队列中763例患者中的426例和验证队列中379例患者中的214例。PD溶液的处方能够完美识别正在接受透析的患者。排除开具PD溶液的患者后,算法纳入了七个实验室参数。推导队列中受试者操作特征曲线下面积分别为0.95和0.98,阳性和阴性预测值分别为90.9%和91.4%;验证队列中分别为96.2%和94.6%。校准几乎呈线性。

结论

我们在eGFR<15ml/min/1.73m²的患者中识别出了透析患者。本研究为肾脏病学的数据库研究铺平了道路,尤其是对于非透析依赖的晚期CKD患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f599/12049401/ffddd59a7bfb/10157_2024_2614_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f599/12049401/4516f6fa8c77/10157_2024_2614_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f599/12049401/fc328d43c21c/10157_2024_2614_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f599/12049401/fe88f8fe83a0/10157_2024_2614_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f599/12049401/ffddd59a7bfb/10157_2024_2614_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f599/12049401/4516f6fa8c77/10157_2024_2614_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f599/12049401/fc328d43c21c/10157_2024_2614_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f599/12049401/fe88f8fe83a0/10157_2024_2614_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f599/12049401/ffddd59a7bfb/10157_2024_2614_Fig4_HTML.jpg

相似文献

1
Development and validation of an algorithm for identifying patients undergoing dialysis from patients with advanced chronic kidney disease.一种用于从晚期慢性肾病患者中识别正在接受透析治疗患者的算法的开发与验证
Clin Exp Nephrol. 2025 May;29(5):650-661. doi: 10.1007/s10157-024-02614-3. Epub 2025 Jan 6.
2
Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study.透析前肾脏病护理下慢性肾脏病进展至终末期肾衰竭的临床预测模型:日本慢性肾脏病队列研究结果
Clin Exp Nephrol. 2019 Feb;23(2):189-198. doi: 10.1007/s10157-018-1621-z. Epub 2018 Aug 1.
3
Primacy of lowered baseline glomerular filtration rate as a risk for incident chronic kidney disease: A longitudinal study in Japanese subjects.基线肾小球滤过率降低作为新发慢性肾脏病风险因素的首要地位:一项针对日本受试者的纵向研究
Nephrology (Carlton). 2017 Sep;22(9):684-689. doi: 10.1111/nep.12836.
4
Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.Elbasvir/grazoprevir 治疗合并慢性肾脏病(包括透析患者)的 1b 型慢性丙型肝炎日本患者的疗效和安全性:一项多中心研究的事后分析。
J Gastroenterol Hepatol. 2019 Feb;34(2):364-369. doi: 10.1111/jgh.14447. Epub 2018 Sep 14.
5
Social determinants of health and dialysis modality selection in patients with advanced chronic kidney disease: A retrospective cohort study.晚期慢性肾病患者的健康社会决定因素与透析方式选择:一项回顾性队列研究。
Perit Dial Int. 2024 Jul;44(4):245-253. doi: 10.1177/08968608241234525. Epub 2024 Mar 6.
6
Applying stacking ensemble method to predict chronic kidney disease progression in Chinese population based on laboratory information system: a retrospective study.基于实验室信息系统的堆叠集成方法在预测中国人群慢性肾脏病进展中的应用:一项回顾性研究。
PeerJ. 2024 Nov 1;12:e18436. doi: 10.7717/peerj.18436. eCollection 2024.
7
Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.肾小球滤过率变化作为日本普通人群终末期肾病未来发病率替代终点的重要性:基于社区的队列研究。
Clin Exp Nephrol. 2018 Apr;22(2):318-327. doi: 10.1007/s10157-017-1463-0. Epub 2017 Sep 7.
8
Incidence of Uncommon Clinical Events in USA Patients with Dialysis-Dependent and Nondialysis-Dependent Chronic Kidney Disease: Analysis of Electronic Health Records from TriNetX.美国透析依赖和非透析依赖慢性肾脏病患者罕见临床事件的发生率:来自 TriNetX 的电子健康记录分析。
Nephron. 2021;145(5):462-473. doi: 10.1159/000516280. Epub 2021 Jun 3.
9
Structured clinical follow-up for CKD stage 5 may safely postpone dialysis.对5期慢性肾脏病患者进行结构化临床随访可安全推迟透析。
J Nephrol. 2015 Aug;28(4):463-9. doi: 10.1007/s40620-014-0123-7. Epub 2014 Jul 18.
10
TRANSITION PERIOD CLINICAL TRAJECTORIES FOR PD VERSUS HD STARTERS.PD 与 HD 首发患者的过渡期临床轨迹。
Perit Dial Int. 2019 Jan-Feb;39(1):42-50. doi: 10.3747/pdi.2017.00252. Epub 2018 Sep 25.

本文引用的文献

1
Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023.《2023年慢性肾脏病循证临床实践指南》要点
Clin Exp Nephrol. 2024 Jun;28(6):473-495. doi: 10.1007/s10157-024-02497-4. Epub 2024 May 7.
2
Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process.真实世界数据:纳入卫生技术评估过程中相关障碍、挑战和机遇的全面文献综述。
J Pharm Pharm Sci. 2024 Feb 28;27:12302. doi: 10.3389/jpps.2024.12302. eCollection 2024.
3
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022.
《2022年抗癌药物治疗期间肾损伤管理临床实践指南的临床问题与良好实践声明》
Clin Exp Nephrol. 2024 Feb;28(2):85-122. doi: 10.1007/s10157-023-02415-0. Epub 2023 Oct 25.
4
Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017.日本成人和儿科人群的肾脏病理学:对 2007 年至 2017 年日本肾脏活检登记数据库的回顾。
J Nephrol. 2023 Nov;36(8):2257-2267. doi: 10.1007/s40620-023-01687-9. Epub 2023 Aug 19.
5
Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes.利用真实世界数据改善糖尿病相关结局的预防和护理。
Diabetes Care. 2023 Jul 1;46(7):1316-1326. doi: 10.2337/dc22-1438.
6
Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function.美国和日本慢性肾脏病患者心血管事件发生风险过高主要由左心室结构和功能介导。
Kidney Int. 2023 May;103(5):949-961. doi: 10.1016/j.kint.2023.01.008. Epub 2023 Feb 2.
7
Current status of real-world big data research in the cardiovascular field in Japan.日本心血管领域真实世界大数据研究的现状
J Cardiol. 2023 Mar;81(3):307-315. doi: 10.1016/j.jjcc.2022.09.006. Epub 2022 Sep 17.
8
Plasma volume expansion reveals hidden metabolic acidosis in patients with diabetic ketoacidosis.血浆容量扩充揭示糖尿病酮症酸中毒患者潜在的代谢性酸中毒。
Intensive Care Med Exp. 2022 Dec;10(1):36. doi: 10.1186/s40635-022-00464-5. Epub 2022 Aug 29.
9
Epidemiology of chronic kidney disease: an update 2022.慢性肾脏病流行病学:2022年最新情况
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.
10
Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.氯沙坦治疗晚期慢性肾脏病的高血压。
N Engl J Med. 2021 Dec 30;385(27):2507-2519. doi: 10.1056/NEJMoa2110730. Epub 2021 Nov 5.